This post originally appeared in October 2013. Since that time, more antipsychotics have appeared on the market and more studies have shown the harm they can cause……
Medication had a significant impact on my son Dan’s journey through severe helpful for some people with OCD, they only seemed to make things worse for Dan. Part of the problem stemmed from his being overmedicated, as well as the fact that he was prescribed drugs that we now know can exacerbate obsessive-compulsive disorder.. While certain drugs appear to be
Atypical antipsychotics (also known as second generation ) are sometimes given to people with OCD to “enhance” the effects of an SSRI. This was the explanation given to us twice, when Dan was prescribed two different antipsychotics. I’ve written previously about some of the side effects he experienced so I won’t go into that here, but suffice it to say no good (and quite a lot of bad) came out of his taking these drugs.
Seth Gillihan, PhD discusses a study conducted by researchers at and The . Participants already taking an SSRI to treat their OCD were separated into three groups. One group was given seventeen sessions of e ( ) therapy, one group was given an atypical antipsychotic, and the final group was given a placebo.
Dr. Gillihan said:
The results after 8 weeks were striking. Individuals in the ERP condition on average had a 52% reduction in their OCD severity scores, whereas those in the risperidone (13% reduction) and placebo (11% reduction) conditions were virtually indistinguishable.
It’s clear. Exposure and response prevention (ERP) therapy is effective. The atypical antipsychotic however, did not provide any statistically significant benefit over that of a placebo. Given this information, I would think long and hard before taking such a heavy-duty medication for the treatment of OCD. Certainly I hope doctors will think long and hard before prescribing it.